These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 10036599

  • 1. A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms/day or levonorgestrel 30 micrograms/day. Collaborative Study Group on the Desogestrel-containing Progestogen-only Pill.
    Eur J Contracept Reprod Health Care; 1998 Dec; 3(4):169-78. PubMed ID: 10036599
    [Abstract] [Full Text] [Related]

  • 2. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
    Coutinho EM, de Souza JC, da Silva AR, de Acosta OM, Alvarez F, Brache V, Garza Flores J, Vasquez-Estrada L, Santo R, Bassol S.
    Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
    [Abstract] [Full Text] [Related]

  • 3. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M, Røde A, Westergaard J.
    Br J Obstet Gynaecol; 1993 Sep; 100(9):832-8. PubMed ID: 8218004
    [Abstract] [Full Text] [Related]

  • 4. A comparison of the inhibition of ovulation achieved by desogestrel 75 micrograms and levonorgestrel 30 micrograms daily.
    Rice CF, Killick SR, Dieben T, Coelingh Bennink H.
    Hum Reprod; 1999 Apr; 14(4):982-5. PubMed ID: 10221231
    [Abstract] [Full Text] [Related]

  • 5. The effects of two progrestogen-only pills containing either desogestrel (75 microgram/day) or levonorgestrel (30 microgram/day) on carbohydrate metabolism and adrenal and thyroid function.
    Kivelä A, Ruuskanen M, Agren U, Dieben T.
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):71-7. PubMed ID: 11518451
    [Abstract] [Full Text] [Related]

  • 6. A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant.
    Zheng SR, Zheng HM, Qian SZ, Sang GW, Kaper RF.
    Contraception; 1999 Jul; 60(1):1-8. PubMed ID: 10549446
    [Abstract] [Full Text] [Related]

  • 7. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
    Rosing J, Middeldorp S, Curvers J, Christella M, Thomassen LG, Nicolaes GA, Meijers JC, Bouma BN, Büller HR, Prins MH, Tans G.
    Lancet; 1999 Dec 11; 354(9195):2036-40. PubMed ID: 10636369
    [Abstract] [Full Text] [Related]

  • 8. The effects of two progestogen-only pills containing either desogestrel (75 microg/day) or levonorgestrel (30 microg/day) on lipid metabolism.
    Barkfeldt J, Virkkunen A, Dieben T.
    Contraception; 2001 Nov 11; 64(5):295-9. PubMed ID: 11777489
    [Abstract] [Full Text] [Related]

  • 9. Comparative study on intermittent versus continuous use of a contraceptive pill administered by vaginal route.
    Coutinho EM, O'Dwyer E, Barbosa IC, Gu ZP, Shaaban MM, Aboul-Oyoon M, Abdel Aleem H.
    Contraception; 1995 Jun 11; 51(6):355-8. PubMed ID: 7554976
    [Abstract] [Full Text] [Related]

  • 10. A comparative study on the effects of a monophasic pill containing desogestrel plus 20 micrograms ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors.
    Melis GB, Fruzzetti F, Nicoletti I, Ricci C, Lammers P, Atsma WJ, Fioretti P.
    Contraception; 1991 Jan 11; 43(1):23-31. PubMed ID: 1825970
    [Abstract] [Full Text] [Related]

  • 11. A multicenter, uncontrolled clinical investigation of the contraceptive efficacy, cycle control, and safety of a new low dose oral contraceptive containing 20 micrograms ethinyl estradiol and 100 micrograms levonorgestrel over six treatment cycles.
    Bannemerschult R, Hanker JP, Wünsch C, Fox P, Albring M, Brill K.
    Contraception; 1997 Nov 11; 56(5):285-90. PubMed ID: 9437556
    [Abstract] [Full Text] [Related]

  • 12. Multicenter trial of a monophasic oral contraceptive containing ethinyl estradiol and desogestrel.
    Rekers H.
    Acta Obstet Gynecol Scand; 1988 Nov 11; 67(2):171-4. PubMed ID: 2972160
    [Abstract] [Full Text] [Related]

  • 13. Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study.
    Endrikat J, Düsterberg B, Ruebig A, Gerlinger C, Strowitzki T.
    Contraception; 1999 Nov 11; 60(5):269-74. PubMed ID: 10717778
    [Abstract] [Full Text] [Related]

  • 14. Phase III clinical trial with a new oral contraceptive containing 150 micrograms desogestrel and 20 micrograms ethinylestradiol.
    Lammers P, op ten Berg M.
    Acta Obstet Gynecol Scand; 1991 Nov 11; 70(6):497-500. PubMed ID: 1837199
    [Abstract] [Full Text] [Related]

  • 15. A new low-dose monophasic combination oral contraceptive (Alesse) with levonorgestrel 100 micrograms and ethinyl estradiol 20 micrograms. North American Levonorgestrel Study Group (NALSG).
    Archer DF, Maheux R, DelConte A, O'Brien FB.
    Contraception; 1997 Mar 11; 55(3):139-44. PubMed ID: 9115001
    [Abstract] [Full Text] [Related]

  • 16. A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, with respect to efficacy, cycle control, and tolerance.
    Endrikat J, Müller U, Düsterberg B.
    Contraception; 1997 Mar 11; 55(3):131-7. PubMed ID: 9115000
    [Abstract] [Full Text] [Related]

  • 17. A comparison of the cycle control and tolerability of two ultra low-dose oral contraceptives containing 20 micrograms ethinylestradiol and either 150 micrograms desogestrel or 75 micrograms gestodene.
    Serfaty D, Vree ML.
    Eur J Contracept Reprod Health Care; 1998 Dec 11; 3(4):179-89. PubMed ID: 10036600
    [Abstract] [Full Text] [Related]

  • 18. The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.
    Lewis MA, Heinemann LA, MacRae KD, Bruppacher R, Spitzer WO.
    Contraception; 1996 Jul 11; 54(1):5-13. PubMed ID: 8804801
    [Abstract] [Full Text] [Related]

  • 19. Progestin-only pills for contraception.
    Grimes DA, Lopez LM, O'Brien PA, Raymond EG.
    Cochrane Database Syst Rev; 2010 Jan 20; (1):CD007541. PubMed ID: 20091638
    [Abstract] [Full Text] [Related]

  • 20. Effect of oral contraceptive progestins on serum copper concentration.
    Berg G, Kohlmeier L, Brenner H.
    Eur J Clin Nutr; 1998 Oct 20; 52(10):711-5. PubMed ID: 9805216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.